|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash Flows from Operating Activities | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Net realized (gains) losses on investments | |
| Asset Management | |
| Total net realized (gains) losses on investments | |
| Net realized (gains) losses on foreign currency | |
| Net change in unrealized (gains) losses on investments | |
| Asset Management | |
| Total net change in unrealized (gains) losses on investments | |
| Net change in unrealized (gains) losses on foreign currency | |
| Change in fair value of debt obligation | |
| Payment in-kind interest | |
| Equity investment earnings | |
| Asset Management | |
| Total equity investment earnings | |
| Amortization of debt issuance costs | |
| Amortization of deferred acquisition costs | |
| Insurance Solutions | |
| Total amortization of deferred acquisition costs | |
| Amortization of intangible assets | |
| Impairment of intangible assets | |
| Net amortization of premiums and accretion of discounts on investments | |
| Equity based compensation | |
| Increase (decrease) in estimated credit losses | |
| Gain on reverse acquisition of business | |
| Goodwill Impairment | |
| Insurance Solutions | |
| Total goodwill Impairment | |
| (Increase) decrease in operating assets: | |
| Reinsurance recoverable | |
| Change in deferred acquisition costs | |
| Distributions from equity method investments | |
| Other assets | |
| Variable Interest Entity, Primary Beneficiary | |
| Consolidated Entity, Excluding Consolidated VIE | |
| Purchases of investments by consolidated VIEs | |
| Proceeds from sale of investments by consolidated VIEs | |
| Increase (decrease) in operating liabilities: | |
| Due to related parties | |
| Future policy benefits | |
| Interest sensitive contract liabilities | |
| Funds held under reinsurance contracts | |
| Accrued expenses and other liabilities | |
| Net cash used in operating activities | |
| Investing Activities | |
| Purchases of investments | |
| Proceeds received from reverse acquisition of business | |
| Proceeds from sales and repayments of investments | |
| Net cash provided by (used in) investing activities | |
| Financing Activities | |
| Shareholder dividends | |
| Repurchase of common shares | |
| Proceeds from borrowings of asset management business | |
| Repayments of borrowings of asset management business | |
| Financing costs paid and deferred | |
| Proceeds from borrowings of insurance business | |
| Deposits on investment-type policies and contracts | |
| Withdrawals on investment-type policies and contracts | |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash, cash equivalents and restricted cash, and cash and cash equivalents of consolidated VIEs | |
| Cash, cash equivalents and restricted cash, and cash and cash equivalents of consolidated VIEs, beginning of the period | |
| Insurance Solutions | |
| Variable Interest Entity, Primary Beneficiary | |
| Cash, cash equivalents and restricted cash, and cash and cash equivalents of consolidated VIEs, end of period | |
| Insurance Solutions | |
| Variable Interest Entity, Primary Beneficiary | |
| Cash and cash equivalents | |
| Restricted cash | |
| Supplemental disclosures of cash flow information | |
| Interest received | |
| Interest paid | |
| Dividends received | |
| Income taxes paid | |
| Supplemental Disclosures of Non-Cash Investing and Financing Activities | |
| Cashless repayment on borrowings | |
| Restricted stock release (in shares) | |
| Issuance of common shares for investment purchases (in shares) | |
| Issuance of common shares for share based compensation |
Loading...
